The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to share how competitors and customers are reacting.
Mr. Bihl feels that orthobiologics are in a unique position to address unmet needs that remain prevalent despite advancements in traditional orthopedic products.
DePuy Synthes declined 7.5% in 1Q20 due to the impact of the COVID-19 pandemic, with the worst expected to come in 2Q as procedures are deferred en masse.
First-quarter earnings announcements start in earnest today. We think a clearer picture of the entire orthopedic market could develop in the next month.
Joint replacement surgeon Vinod Dasa, M.D., says there will be a heightened focus on eliminating waste and redundancies, especially in the “last mile” of the supply chain.
The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to keep you abreast of ways that competitors and customers are reacting to COVID-19.